AVANTOR (AVTR) Q4 2019 Earnings Call Transcript

AVANTOR (AVTR) Q4 2019 Earnings Call Transcript

Our speakers today are Michael Stubblefield, President and Chief Executive Officer; and Tom Szlosek, Executive Vice President and Chief Financial Officer.. We appreciate you joining our fourth quarter earnings call.. In addition to having strong revenue growth across all of our biopharma business, continued margin expansion and robust cash generation, we made great progress in executing our growth strategy and expanding our global capabilities.. Dev Ohri is serving as Executive Vice President for IMEA, and we've hired Sven Henrichwark as our new Executive Vice President for the Asia-Pacific region.. We welcome to Mark Murray to Avantor as Executive Vice President of the Biomaterials and Advanced Technologies platform.. Marc Centrella joined Tom's organization in December as Vice President, Corporate Strategy and M&A.. Organic revenue growth was 4.3% for the period and 5.1% for the full year, including high single-digit growth in our biopharma business in the fourth quarter, reflecting ongoing strength in our portfolio of customized proprietary solutions.. The other growth platforms that we have discussed, including services and biomaterials, also had high single-digit growth in the quarter.. Our adjusted EBITDA margin for the quarter was up 12.4%, excluding adverse currency impacts, reflecting an improvement of 131 basis points for the